SRx Health Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 17, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Market Capitalization	4	8	-	-	-
Enterprise Value	12	44	-	-	-
Last Close Price	0.15	0.32	-	-	-
PS Ratio	0.38	1.21	-	-	-
PB Ratio	1.11	19.36	-	-	-
P/TBV Ratio	-	19.36	-	-	-
EV/Sales Ratio	1.27	6.73	-	-	-
Debt / Equity Ratio	5.97	10.99	-0.82	-2.86	19.25
Debt / EBITDA Ratio	-	-	-	-	156.04
Debt / FCF Ratio	-	-	-	25.00	5.70
Net Debt / Equity Ratio	2.26	7.77	-0.82	-2.71	17.46
Net Debt / EBITDA Ratio	-0.61	-0.39	-	-5.30	-30.02
Net Debt / FCF Ratio	-	-0.19	-30.58	23.68	5.17
Asset Turnover	-	0.31	-	2.58	-
Inventory Turnover	-	1.84	-	19.45	-
Quick Ratio	0.69	1.48	0.12	0.17	0.47
Current Ratio	0.80	2.29	0.17	0.27	0.67
Return on Assets (ROA)	-	-24.03%	-	-11.92%	-
Return on Capital Employed (ROCE)	-337.60%	-166.80%	-	104.00%	-9.10%
Earnings Yield	-1274.50%	-571.24%	-	-	-
FCF Yield	-	-211.53%	-	-	-
Buyback Yield / Dilution	-7.10%	4.40%	-78.22%	-1659.27%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q